The Board of Star Combo Pharma Limited announced that it has received the full proceeds of the private placement from Goldenmax International Technology Ltd. (Goldenmax), and as approved by shareholders at the Extraordinary General Meeting (EGM) held on the 23rd April 2020 has issued 49,000,000 million shares to Goldenmax. The Company welcomes Goldenmax as a substantial shareholder (36.1%) and the appointment of two directors from Goldenmax onto the Board of Star Combo. Appointment of Mr. Jialong Ding ­- vice president of Pharmaceutical division of Goldenmax, former director, chairman, CEO and senior executive of several large pharmaceutical companies in China. Appointment of Ms. Wei Han ­- vice chairperson and executive director of Goldenmax, with over 30 years of experience in business and financial management.